SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-03-002443
Filing Date
2003-03-04
Accepted
2003-03-04 17:24:58
Documents
9
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 TEVA PHYARMACEUTICAL INDUSTRIES LIMITED y84058e20vf.htm 20-F 1374448
3 SUBSIDIARIES y84058exv99w8.htm EX-99.8 12121
4 CONSENT OF KESSELMAN & KESSELMAN y84058exv99w10w1.htm EX-99.10.1 1498
5 CONSENT OF KPMG HUNGARIA KFT y84058exv99w10w2.htm EX-99.10.2 2248
6 CONSENT OF EHRENKRANTZ STERLING & CO. LLC y84058exv99w10w3.htm EX-99.10.3 1425
7 CERTIFICATION OF CHIEF EXECUTIVE OFFICER y84058exv99w10w4wi.htm EX-99.10.4.I 1908
8 CERTIFICATION OF CHIEF FINANCIAL OFFICER y84058exv99w10w4wii.htm EX-99.10.4.II 1928
9 GRAPHIC y84058y8405801.gif GRAPHIC 7192
10 GRAPHIC y84058y8405802.gif GRAPHIC 1520
  Complete submission text file 0000950123-03-002443.txt   1406936
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 000-16174 | Film No.: 03592052
SIC: 2834 Pharmaceutical Preparations